Open AccessDifferential Growth Rates and In Vitro Drug Susceptibility to Currently Used Drugs for Multiple Isolates of Naegleria fowleri
Author(s) -
A Cassiopeia Russell,
Dennis E. Kyle
Publication year - 2022
Publication title -
microbiology spectrum
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.502
H-Index - 51
ISSN - 2165-0497
DOI - 10.1128/spectrum.01899-21
Subject(s) - naegleria fowleri , biology , naegleria , drug , disease , microbiology and biotechnology , meningoencephalitis , medicine , pharmacology , acanthamoeba , virology
Naegleria fowleri , also known as the brain-eating amoeba, is ubiquitous in warm freshwater and is an opportunistic pathogen that causes primary amoebic meningoencephalitis. Although few cases are described each year, the disease has a case fatality rate of >97%.